Fennec Pharmaceuticals Inc. (FENC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 7.31 |
| Open | 7.32 |
| Bid | 7.08 x 400 |
| Ask | 7.16 x 400 |
| Day's range | 7.08 - 7.43 |
| 52-week range | 6.30 - 11.92 |
| Volume | |
| Avg. volume | 169,132 |
| Market cap | 194.533M |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | 178.00 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) largest shareholders are individual investors who were rewarded as market cap surged US$25m last week
Key Insights The considerable ownership by individual investors in Fennec Pharmaceuticals indicates that they...
- Simply Wall St.
Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136%
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
- GuruFocus.com
Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)
Fennec Pharmaceuticals Inc (NASDAQ:FENC), a biopharmaceutical company focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients, has reported a significant insider sell transaction.
© 2024 Yahoo. All rights reserved.